Complete Response to Temozolomide in Metastatic Melanoma After Failure of 5 Lines of Treatment

被引：4
|
作者：
Magge, Tara [1 ]
Shaikh, Hira [2 ]
Chaudhary, Rekha [2 ]
机构：
[1] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA
[2] Univ Cincinnati, Dept Hematol & Oncol, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2022年 / 29卷 / 06期
关键词：
PHASE-III; CHEMOTHERAPY; SURVIVAL; INHIBITORS; NIVOLUMAB; RATES;
D O I：
10.1097/MJT.0000000000001186
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E767 / E769
页数：3
相关论文
共 50 条
  • [21] Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanoma
    Lee, Jenny H. J.
    Lyle, Megan
    Menzies, Alexander M.
    Chan, Matthew M. K.
    Lo, Serigne
    Clements, Arthur
    Carlino, Matteo S.
    Kefford, Richard F.
    Long, Georgina, V
    PIGMENT CELL & MELANOMA RESEARCH, 2018, 31 (03) : 404 - 410
  • [22] Complete responses and survival after polychemotherapy plus interferon-alpha for patients with metastatic melanoma
    Vuoristo, MS
    MELANOMA RESEARCH, 1996, 6 (04) : 331 - 336
  • [23] Treatment options after regorafenib failure in metastatic colorectal cancer
    Eraslan, E.
    Dogan, M.
    Yildiz, F.
    Ilhan, A.
    Oksuzoglu, O. B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (09) : 3470 - 3477
  • [24] Intracranial response after extracranial radiation in a patient with rapidly progressing metastatic melanoma
    Piercey, Oliver
    Tomaszewski, Jonathan Mark
    Smith, Kortnye
    BMJ CASE REPORTS, 2021, 14 (06)
  • [25] Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
    Laeubli, Heinz
    Balmelli, Cathrin
    Bossard, Matthias
    Pfister, Otmar
    Glatz, Kathrin
    Zippelius, Alfred
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [26] The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis
    Ryden, Viktoria
    El-Naggar, Ali Inan
    Koliadi, Anthoula
    Ladjevardi, Cecilia Olsson
    Digkas, Evangelos
    Valachis, Antonios
    Ullenhag, Gustav J.
    PIGMENT CELL & MELANOMA RESEARCH, 2024, 37 (03) : 352 - 362
  • [27] Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities
    Furudate, Sadanori
    Fujimura, Taku
    Kambayashi, Yumi
    Hidaka, Takanori
    Hashimoto, Akira
    Aiba, Setsuya
    CASE REPORTS IN ONCOLOGY, 2016, 9 (03): : 644 - 649
  • [28] Sustained Exceptional Response to Poly (ADP-Ribose) Polymerase Inhibition Plus Temozolomide in Metastatic Melanoma With DNA Repair Deficiency
    Kiel, Patrick J.
    Radovich, Milan
    Schneider, Bryan P.
    Logan, Theodore F.
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 7
  • [29] Evaluation of patients with metastatic renal cell carcinoma after failure of first-line treatment
    Carles, Joan
    Chirivella, Isabel
    Angel Climent, Miguel
    Gallardo, Enrique
    Gonzalez del Alba, Arancha
    Pablo Maroto, Jose
    Mellado, Begona
    Garcia del Muro, Francisco Xavier
    CANCER AND METASTASIS REVIEWS, 2012, 31 : S3 - S9
  • [30] Retreatment of Patients With Metastatic Cutaneous Melanoma Who Relapse After Elective Checkpoint Inhibitor Discontinuation After a Complete Remission
    Sadrolashrafi, Kaviyon
    Samlowski, Wolfram
    ONCOLOGIST, 2023, 28 (05): : E270 - E275
12345